UiPath (NYSE:PATH - Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from $16.00 to $15.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Canaccord Genuity Group's price target would suggest a potential upside of 29.59% from the company's previous close.
A number of other analysts have also recently issued reports on PATH. Barclays restated an "equal weight" rating on shares of UiPath in a research note on Friday, May 30th. Needham & Company LLC reiterated a "hold" rating on shares of UiPath in a report on Friday. Wall Street Zen upgraded shares of UiPath from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Scotiabank increased their target price on shares of UiPath from $12.00 to $13.00 and gave the stock a "sector perform" rating in a research note on Friday, May 30th. Finally, Wells Fargo & Company reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Two equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $13.18.
View Our Latest Stock Report on UiPath
UiPath Trading Up 0.7%
Shares of PATH traded up $0.09 during mid-day trading on Monday, hitting $11.58. 6,287,515 shares of the company traded hands, compared to its average volume of 11,800,887. UiPath has a one year low of $9.38 and a one year high of $15.93. The business has a 50-day moving average of $11.76 and a 200 day moving average of $11.80. The stock has a market capitalization of $6.19 billion, a price-to-earnings ratio of 385.83, a PEG ratio of 12.07 and a beta of 1.02.
UiPath (NYSE:PATH - Get Free Report) last released its earnings results on Thursday, September 4th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.07. The firm had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. UiPath had a return on equity of 1.27% and a net margin of 1.35%.The company's quarterly revenue was up 14.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, analysts anticipate that UiPath will post -0.17 earnings per share for the current year.
Insider Activity at UiPath
In other news, CEO Daniel Dines sold 9,988 shares of the business's stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $12.00, for a total transaction of $119,856.00. Following the sale, the chief executive officer owned 4,598,388 shares in the company, valued at approximately $55,180,656. The trade was a 0.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last quarter, insiders have sold 831,310 shares of company stock worth $10,428,922. Insiders own 23.19% of the company's stock.
Hedge Funds Weigh In On UiPath
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Northern Trust Corp lifted its position in shares of UiPath by 9.9% during the 4th quarter. Northern Trust Corp now owns 2,303,207 shares of the company's stock valued at $29,274,000 after buying an additional 208,307 shares in the last quarter. Mercer Global Advisors Inc. ADV purchased a new position in shares of UiPath during the 4th quarter worth about $245,000. Ameriprise Financial Inc. boosted its position in shares of UiPath by 15.8% during the fourth quarter. Ameriprise Financial Inc. now owns 471,346 shares of the company's stock valued at $5,990,000 after buying an additional 64,141 shares during the period. Captrust Financial Advisors grew its holdings in shares of UiPath by 85.3% in the fourth quarter. Captrust Financial Advisors now owns 67,119 shares of the company's stock worth $853,000 after purchasing an additional 30,894 shares during the last quarter. Finally, Cetera Investment Advisers increased its stake in shares of UiPath by 55.1% during the fourth quarter. Cetera Investment Advisers now owns 73,044 shares of the company's stock valued at $928,000 after buying an additional 25,954 shares during the period. Institutional investors own 62.50% of the company's stock.
About UiPath
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.